Objective: The objective of this article is to report the first case of intravesical IUD migration at our clinic and raise awareness of forgotten contraceptive devices and their potential complications.
Methods: We report a case of a 67 year old female who had neglected to remove her IUD for 20 years. She visited our clinic because of recurrent UTI's the previous year. After assessment and clinical investigation it was found that the coil had a late onset migration to the urinary bladder, with calculus formation, causing the patients' symptoms. The encrusted intrauterine device was removed endoscopically after cystolitholapaxy at the operation theatre under anesthesia.
Results: The patient had an uneventful recovery and her UTI's subsided consequently.
Conclusion: Recurrent urinary tract infections should trigger further investigation. Gynecological history should be included in this procedure. A history of an unretrieved IUD in a patient with recurrent infections or with chronic pelvic pain and irritative voiding symptoms should raise the suspicion of intravesical migration of the IUD. The management of a migrated IUD is controversial. However, if the IUD is found in the urinary bladder removal is mandatory.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.urology.2020.02.009 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Modulation of persistent bladder pain in mice: The role of macrophage migration inhibitory factor, high mobility group box-1, and downstream signaling pathways.
Bladder (San Franc)
October 2024
Lexington VA Health Care System, Research and Development, Lexington, KY, USA.
Background: Repeated intravesical activation of protease-activated receptor-4 (PAR4) serves as a model of persistent bladder hyperalgesia (BHA) in mice, which lasts several days after the final stimulus. Spinal macrophage migration inhibitory factor (MIF) and high mobility group box 1 (HMGB1) are critical mediators in the persistence of BHA.
Objective: We aimed to identify effective systemic treatments for persistent BHA using antagonists or transgenic deletions.
The Laws of Attraction: Chemokines as Critical Mediators in Cancer Progression and Immunotherapy Response in Bladder Cancer.
Cancers (Basel)
September 2024
Department of Urology, University of Texas Health Science Center at San Antonio (UTHSCSA), San Antonio, TX 78229, USA.
Bladder cancer (BCa) is a prevalent urogenital malignancy, characterized by a myriad of genetic and environmental risk factors that drive its progression. Approximately 75% of bladder tumors are non-muscle-invasive at diagnosis. For such cases, bladder preservation is often feasible with intravesical chemotherapy or immunotherapy.
View Article and Find Full Text PDFA mucoadhesive-to-penetrating nanomotors-in-hydrogel system for urothelium-oriented intravesical drug delivery.
J Nanobiotechnology
September 2024
Urology & Nephrology Center, Department of Urology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China.
Intravesical therapy (IT) is widely used to tackle various urological diseases. However, its clinical efficacy is decreased by the impermeability of various barriers presented on the bladder luminal surface, including the urinary mucus layer and the densely packed tissue barrier. In this study, we report a mucoadhesive-to-penetrating nanomotors-in-hydrogel system for urothelium-oriented intravesical drug delivery.
View Article and Find Full Text PDFIntrauterine contraceptive device (IUCD) migration into the bladder with bladder stone formation: Case report.
Urol Case Rep
September 2024
Addis Ababa University College of Health Sciences, Addis Ababa, Ethiopia.
Intrauterine contraceptive device (IUCD) is commonly used to prevent unwanted pregnancy. Migration of IUCD into the bladder is a rare complication. We present a case of a 38-year-old woman with a history of IUCD insertion 05 years ago, immediately following her last delivery.
View Article and Find Full Text PDFMigration of an intrauterine contraceptive device into the bladder complicated by stone formation an exceptional complication: case report and literature review.
Contracept Reprod Med
August 2024
Gynecology Obstetrics Departement, Mohammed the VI University Medical Center, Cadi Ayyad University, Marrakesh, Morocco.
Background: We report a rare and unusual case of intravesical migration of an intrauterine device with stone formation. The intrauterine device (IUD) is the most common method of reversible contraception in women. However, its insertion is not without risk, it can cause early or late complications.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!